Yearly Archives: "2016"

Taste sensory deficit underestimated in multiple sclerosis patients
Multiple sclerosis (MS) patients may exhibit taste sensory deficits more often than previously understood, according to [...]
Multiple sclerosis patients take part in survey of risk/benefit considerations in choosing treatments
The National Multiple Sclerosis Society is funding a new survey to understand how people living with multiple sclerosis (MS) weigh risks [...]
5 important tools in multiple sclerosis diagnosis
A thorough physical examination of the patient and knowledge of his or her medical history is a must in an accurate multiple sclerosis [...]
Multiple sclerosis treatment, faster MRI diagnosis method helps reduce brain inflammation
New multiple sclerosis treatment has been uncovered, along with faster MRI diagnosis method to help reduce brain inflammation. Researchers [...]
Young multiple sclerosis patients in United States more likely overweight & suffer relapses than peers – study
Scientists at the Pediatric MS Center at NYU Langone, New York, reported that U.S. adolescents with multiple sclerosis (MS) receiving [...]
Alemtuzumab (Lemtrada) seen to slow disease progression by targeting key brain systems
Several clinical trials have shown that alemtuzumab (Lemtrada) effectively reduces relapse rates in patients with multiple sclerosis [...]
Plant peptide could prevent onset of multiple sclerosis
MedUni Vienna has made a crucial development in the treatment of Multiple Sclerosis (MS): Together with his team and the research group led [...]
MRI could be used for multiple sclerosis diagnostics
Evidence of multiple sclerosis (MS) can be detected using magnetic resonance imaging (MRI) scanners in the near future, according to [...]
Multiple sclerosis: comorbidities common at diagnosis
Patients newly diagnosed with multiple sclerosis (MS) often have other chronic medical conditions, with fibromyalgia, inflammatory bowel [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last

Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM